Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Timothy Schmidt

11PUBLICATIONS

32CO-AUTHORS

Forensic epidemiologyGene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 04, 2024

Extended DaraKRd: Are we enhancing outcomes by prolonging treatment?

Timothy M Schmidt

|Apr 22, 2024

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.

Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman

|Jan 25, 2024

Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review.

Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal

|Dec 15, 2023

Update on the current and future use of CAR-T to treat multiple myeloma.

Zhubin Gahvari, Matthew Brunner, Timothy Schmidt

|Aug 21, 2023

Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell transplantation, and measurable residual disease-response-adapted treatment cessation.

Rebecca W Silbermann, Timothy Martin Schmidt, Susan Bal

|Jun 07, 2023

Making a case for del(1p) as a high-risk abnormality in multiple myeloma.

Timothy M Schmidt

Pageof 2

Frequent Collaborators

4 joint publications

Natalie S Callander

3 joint publications

Luciano J Costa

2 joint publications

Parameswaran Hari

2 joint publications

Jonathan L Kaufman

2 joint publications

Rafael Fonseca

2 joint publications

Saad Z Usmani

2 joint publications

Saurabh Chhabra

2 joint publications

Binod Dhakal

2 joint publications

Bhagirathbhai R Dholaria

2 joint publications

Rebecca W Silbermann

Frequent Collaborators

4 joint publications

Natalie S Callander

3 joint publications

Luciano J Costa

2 joint publications

Parameswaran Hari

2 joint publications

Jonathan L Kaufman

Top Related Videos

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on : Apr 16, 2019

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on : Jul 15, 2015

See more related videos

Top Related Videos

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on : Apr 16, 2019

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on : Jul 15, 2015

See more related videos